Edesa Biotech (EDSA)
Develops clinical candidates for inflammatory and immune-related diseases.
$4.77
At close−0.01 (−0.21%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Aug '26
Reported−$0.48−$0.30−$0.25−$0.32−$0.28−$0.49−$0.60−$0.60
Estimate−$0.31−$0.30−$0.26−$0.27−$0.28−$0.24−$0.44−$0.44
Surprise−54.8%0.0%+3.8%−18.5%0.0%−104.2%−37.9%−37.9%
RevenueReportedEstimate
Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.44 | −$0.60 | −37.9% |
| Aug 2026 | −$0.44 | −$0.60 | −37.9% |
| May 2026 | −$0.24 | −$0.49 | −104.2% |
| Feb 2026 | −$0.28 | −$0.28 | 0.0% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Dec 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Dec 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Dec 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Dec 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Dec 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Dec 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Dec 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Dec 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Dec 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | −$0.44 | −$0.60 | −37.9% | — | — | — | +5.6% |
| Aug 13, 2026 | −$0.44 | −$0.60 | −37.9% | — | — | — | −1.5% |
| May 14, 2026 | −$0.24 | −$0.49 | −104.2% | — | — | — | −10.7% |
| Feb 13, 2026 | −$0.28 | −$0.28 | 0.0% | — | — | — | 0.0% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||||||
| Dec 12, 2025 | |||||||
| Aug 8, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 14, 2025 | |||||||
| Dec 13, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 10, 2024 | |||||||
| Feb 9, 2024 | |||||||
| Dec 15, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 10, 2023 | |||||||
| Dec 16, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 13, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Dec 28, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 14, 2021 | |||||||
| Feb 16, 2021 | |||||||
| Dec 7, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 15, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Dec 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 5, 2019 | |||||||
| Nov 30, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 5, 2018 | |||||||
| Dec 1, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 7, 2017 | |||||||
| Dec 14, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 9, 2016 | |||||||
| Feb 8, 2016 | |||||||
| Dec 14, 2015 | |||||||
| Aug 10, 2015 | |||||||